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Atrial fi brillation has been called the modern epidemic in cardiology by 
Dr E Braunwald (Shattuck Lecture).(1) The actual incidence is apparently 
steadily increasing particularly in the ever-expanding elderly population. 
At least 9% of octogenarians suffer from atrial fi brillation.(2) This slowly 
increasing prevalence with age strongly suggests an ongoing pathogenic 
mechanism. The presence of atrial fi brillation is associated with a 
decrease in life expectancy and an increase in morbidity due to systemic 
thromboembolism and association with cardiac failure through 
mechanisms not completely understood but almost certainly as a 
result of a rapid, irregular rhythm.(3) 
The best and most widely accepted form of treatment for atrial 
fi brillation is to fi nd and remove the cause. Regrettably this is usually 
not possible. 
Current therapy of atrial fi brillation usually is traditionally divided into 
rhythm control (where the attempt is to restore and maintain sinus 
rhythm) and rate control. Anticoagulation therapy is of course essential 
but will not be commented on further here. Both of these strategies 
can be addressed by either pharmacological or non-pharmacological 
therapies.
Although the AFFIRM substudy(4) in a predominantly elderly population 
demonstrated no clear advantage of either strategy, it was shown that 
no matter how sinus rhythm was obtained its presence imparted a 
better prognosis. However, a non-signifi cant increase in mortality was 
noted in that group of patients receiving pharmacological therapy for 
rhythm control in terms of higher morbidity and mortality.(5) 
The antiarrhythmic drugs utilized for rhythm control are known to 
have a low effi cacy (the highest being with Amiodarone) seldom 
reaching 60% long-term control. Most are associated with potentially 
fatal proarrhythmia and Amiodarone with other serious or even fatal 
non-cardiac side effects, although a very low (but present) potential for 
proarrhythmia exists.
The drugs utilized for rate control are mainly beta blockers or calcium 
antagonists. Digitalis exerts its rate control properties via vagal 
stimulation and provides little or no rate control when parasympathetic 
stimulation is withdrawn. Thus rate control during exercise or with 
sympathetic stimulation (e.g. infection, exercise or heart failure) is poor. 
Neither beta blockade nor calcium antagonists, although widely utilized, 
can be safely given to all patients and often are ineffi cient.
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  Atrial fi brillation has reached epidemic 
proportions and is associated with important increases in 
mortality and morbidity. This increased risk is most 
prominent in patients with heart failure. 
Apart from anticoagulation, therapeutic approaches are: 
attempts (mainly pharmacological) at rhythm control 
(attainment and preservation of sinus rhythm) or rate 
control, which focuses on attaining an acceptable ventri-
cular rate. The latter can be reliably and easily attained 
by ablation of the AV node and pacing. Long-term (up to 
120 months) results of AV nodal ablation and pace are 
reviewed in 147 patients with NYHA Grade III or IV heart 
failure and atrial fi brillation and presented. This analysis 
indicates that AV node ablation is an effective form of 
therapy since prognosis after AV node ablation relates 
entirely to the underlying illness and not the atrial 
fi brillation. SAHeart 2008; 5:171-173
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Non-pharmacological treatments for the “curative” ablation of atrial 
fi brillation mainly take place in the left atrium and fi nd their major 
application in young and middle-aged patients with paroxysmal atrial 
fi brillation although some success can be obtained by ablation therapy 
of the persistent variety. For chronic atrial fi brillation the results 
are considerably worse and patients are more likely to have an 
early relapse. It is diffi cult to envisage long-term success in the 
elderly, particularly in the light of what seems to be an ongoing 
pathological process.
The use of the pacing techniques, mainly atrial based, are now known 
to have value only in those patients with very low sinus rates.  Ventricular 
pacing has been used in the past to guarantee a safe ventricular rate 
when using high doses of calcium blockers or beta blockers to obtain 
control of rapid but unstable ventricular response. This approach is 
rarely satisfactory, usually because of ineffi ciency but frequently as a 
result of unacceptable drug side effects following the high doses 
required to obtain adequate rate control. 
In 1982, independently, Gallagher and Scheinman explored ablation of 
the AV node by physical means combined with ventricular pacing for 
the treatment of drug resistant supra-ventricular arrhythmias, mainly 
atrial fi brillation. There is a natural reluctance in destroying a normally 
functioning AV node and “condemn” the patient to a life of pacemaker 
dependence. At one time attempts were made to ablate only part of 
the AV node, the slow pathway, which has a much lower refractory 
period and thus facilitates the conduction of more impulses per minute. 
This approach, which aimed at controlled AV conduction (thus obviating 
the need for permanent ventricular pacing), was however unreliable 
and relatively ineffi cient and is no longer used. 
Experience over the years has shown AV nodal ablation with ventricular 
pacing to be highly reliable, extremely well accepted by most patients 
and easily performed. The procedure is easily applied to most patients, 
including those of advanced age (a great advantage when reviewing the 
demography of atrial fi brillation).
FIGURE 1: Survival curve (150 months) following AV node ablation and predominantly right ventricular pacing (33 biventricular) in 147 patients Grade III and IV heart failure.
Survival is basically related to the underlying cardiac illness. The cause of death in the ischemic group followed further coronary events. The group with cardiomyopathy was intermediate between 
ischemic and other non-ischemic causes. For other patients with heart failure and uncontrollable atrial fi brillation survival post AV nodal ablation matched normal patients’ age and sex.(8)
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Further doubt as to the value of therapeutic efforts to ensure sinus 
rhythm by pharmacological methods have recently increased.(6,7)
In spite of the reluctance to destroy a normal functioning AV node, the 
diffi culty of attaining drug mediated rate control has resulted in fairly 
wide utilization of this technique.  Initially a wide variety of patients with 
a variety of supra-ventricular arrhythmias were so treated, including 
paroxysmal atrial fi brillation, typical atrial fl utter and others, which can 
now be effectively treated or even cured with other methods of 
radiofrequency ablation. AV node ablation in these patients is totally 
unacceptable. 
The association between heart failure and chronic atrial fi brillation is 
complex. Briefl y, atrial fi brillation may aggravate, complicate or even 
cause heart failure. What is clear, however, is that rapid atrial fi brillation 
that does not come under control with conventional heart failure 
therapy is associated with a very poor prognosis – particularly in 
patients with NYHA grades III or IV disability. Attempts at rhythm 
control in chronic cases often fail or may cause signifi cant deterioration 
in the patient’s condition. In these circumstances an urgent “ablate and 
pace” strategy is frequently dramatic in relief brought to such patients. 
It may indeed be life saving.(6)
The relationship between “ablate and pace” and heart failure is also 
complex. We have recently learned that right ventricular apical pacing 
may cause deterioration in the patient’s hemodynamic state by inducing 
left bundle branch block type dyssynchrony in some patients. Such 
patients respond well to bi-ventricular pacing. It is currently not possible 
to predict which patients will require bi-ventricular pacing ab initio and 
the need may only manifest some time after the initial “pace and ablate” 
strategy has been employed. Thus, upgrade to biventricular pacing can 
be electively done at a later stage, often when the initial crisis has 
passed. The extent to which right ventricular septal, para-Hissian or 
even His bundle pacing will alleviate the problem is not yet clear. 
“Pace and ablate” in correctly chosen patients (usually a clinical decision 
based on the inability to control rapid ventricular response in a chronic 
setting) and often associated with heart failure is associated with an 
increased quality of life, loss of the symptoms of palpitations or drug 
side effects and probably an improved life expectancy (see Figure 1). 
The technique is often valuable in the setting of bi-ventricular pacing 
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where atrial fi brillation overrides the paced rhythm, which can then 
have little benefi t. It is a simple technique to learn and, in the author’s 
view, is often the treatment of choice for poorly controlled chronic 
atrial fi brillation, particularly in the aged. 
